Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ALKALA S is a dietary supplement developed and manufactured by SANUM-Kehlbeck GmbH & Co. KG, formulated as a base citrate powder for oral administration. It contains a combination of three essential minerals in their citrate forms: potassium citrate, magnesium citrate, and calcium citrate, provided in proportions similar to those found in natural food sources and the human body. The product is designed to support the regulation of mineral balance and acid-base homeostasis, helping to prevent overacidification of the organism. The citrate-based formulation is intended to ensure high bioavailability, allowing the minerals to enter cells directly to support intracellular pH regulation. It is marketed for general wellness support, including the maintenance of normal bones and teeth, reduction of tiredness and fatigue, and support of normal nervous system and muscle function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ALKALA S.